Drug Search Results
More Filters [+]

Flunisolide

Alternative Names: flunisolide, aerospan hfa, aerobid, nasarel, nasalide
Latest Update: 2023-01-09
Latest Update Note: News Article

Product Description

Flunisolide nasal spray is used to relieve symptoms of sneezing, runny, stuffy, or itchy nose caused by hay fever or other allergies. Flunisolide nasal spray should not be used to treat symptoms (e.g., sneezing, stuffy, runny, itchy nose) caused by the common cold. It is in a class of medications called corticosteroids. It works by blocking the release of certain natural substances that cause allergy symptoms. (Sourced from: https://medlineplus.gov/druginfo/meds/a685022.html)

Mechanisms of Action: GR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | Colombia | Germany | India | Ireland | Italy | New Zealand | Pakistan | Peru | Portugal | Slovenia | United Kingdom | United States | Venezuela

Approved Indications: Asthma

Known Adverse Events: Headache | Spasm | Pharyngitis | Tuberculosis | Tuberculosis, Ocular | Tuberculosis, Oral | Tuberculosis, Renal | Cataract | Glaucoma | Rhinitis | Sinusitis | Chickenpox | Herpes Simplex | Measles

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Flunisolide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events